NCT06116292
Impact of the Implementation of a Telemedicine Program on Patients Diagnosed With Asthma
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 4 versions: 4 with changes below. See every version on ClinicalTrials.gov ↗
Notable Eligibility criteria expanded, about 9 words Show 7 more changesShow less
- Trial completed
- Final enrollment: 75 participants (planned 108)
- Primary completion date changed from estimate of Dec 31, 2026 to Jan 29, 2026
- Secondary endpoints: 4 to 7
- Study description revised
- Site details revised
- Publications: details revised at 30 of 31 entries
- Notable Trial status: Not Yet Recruiting to Recruiting
- Study sites: 0 to 1
- Minor Study title expanded, about 1 wordv2
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
Asthma Control Test (ACT)
Timeframe: Visit 1 (week 0), visit 2 (week 26) and visit 3 (week 52)
Number of exacerbations
Timeframe: Visit 1 (week 0), visit 2 (week 26) and visit 3 (week 52).
Peak Expiratory Flow (PEF)
Timeframe: Visit 1 (week 0), visit 2 (week 26) and visit 3 (week 52)
Forced expiratory volume in one second (FEV1)
Timeframe: Visit 1 (week 0), visit 2 (week 26) and visit 3 (week 52)
Secondary (7)
Test of the Adherence to Inhalers (TAI).
Electronic history of medication dispenses
Asthma Quality of Life Questionnaire (AQLQ)
The Hospital Anxiety and Depression Scale (HADS)
Asthma knowledge
Show 2 moreShow less
Hyperventilation symptoms
Asthma-related healthcare use
Arms and interventions
Mobile application ESTOI for Asthmatic patientsExperimental
The intervention group will receive the usual care, in addition to having access to the ESTOI application.
Standard of careNo intervention
The intervention group will receive the usual care
Devices: The mobile application ESTOI for Asthmatic patients
Sites
1 site in 1 country
- Bellvitge University HospitalBarcelona, Barcelona, Spain